Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q61467471 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000021.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q61467471 | ||
| 024 | ‡a 0000-0002-8693-5792 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q61467471 | ||
| 100 | 0 | ‡a Sung Yong Lee ‡c internal medicine researcher ORCID ID = 0000-0002-8693-5792 ‡9 en | |
| 400 | 0 | ‡a Sung Yong Lee ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Asthma-like symptoms are increased in the metabolic syndrome | ||
| 670 | ‡a Author's Bacterial and Viral Identification Rate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea | ||
| 670 | ‡a Author's Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity | ||
| 670 | ‡a Author's Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors | ||
| 670 | ‡a Author's Clinical Effectiveness of High-Flow Nasal Cannula in Hypoxaemic Patients during Bronchoscopic Procedures. | ||
| 670 | ‡a Author's Comparison of the Efficacy between Pemetrexed plus Platinum and Non-Pemetrexed plus Platinum as First-Line Treatment in Patients with Wild-Type Epidermal Growth Factor Receptor Nonsquamous Non-Small Cell Lung Cancer: A Retrospective Analysis | ||
| 670 | ‡a Author's Curious case of combined small- and squamous cell carcinoma | ||
| 670 | ‡a Author's Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study | ||
| 670 | ‡a Author's Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping | ||
| 670 | ‡a Author's Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD | ||
| 670 | ‡a Author's Effects of transglutaminase 2 inhibition on ventilator-induced lung injury. | ||
| 670 | ‡a Author's Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study. | ||
| 670 | ‡a Author's infection increases the readmission rate of COPD patients | ||
| 670 | ‡a Author's Invasive Endobronchial Mycobacterium kansasii Infection | ||
| 670 | ‡a Author's Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A | ||
| 670 | ‡a Author's Presence of lung cancer and high gender, age, and physiology score as predictors of acute exacerbation in combined pulmonary fibrosis and emphysema: A retrospective study | ||
| 670 | ‡a Author's Prognostic Factors and Skeletal-Related Events in Patients with Small Cell Lung Cancer with Bone Metastases at the Time of Diagnosis. | ||
| 670 | ‡a Author's Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis | ||
| 670 | ‡a Author's Respiratory bronchiolitis-associated interstitial lung disease in a nonsmoker: radiologic and pathologic findings | ||
| 670 | ‡a Author's The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease. | ||
| 670 | ‡a Author's The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma | ||
| 670 | ‡a Author's The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA | ||
| 670 | ‡a Author's The effect of an IκB-kinase-β | ||
| 670 | ‡a Author's The effect of an IκB-kinase-β(IKKβ) inhibitor on tobacco smoke-induced pulmonary inflammation | ||
| 909 | ‡a (orcid) 0000000286935792 ‡9 1 | ||
| 919 | ‡a curiouscaseofcombinedsmallandsquamouscellcarcinoma ‡A Curious case of combined small- and squamous cell carcinoma ‡9 1 | ||
| 919 | ‡a detectionofegfrmutationsincirculatingfreednabypnamediatedpcrclamping ‡A Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping ‡9 1 | ||
| 919 | ‡a differenceinsystemicinflammationandpredictorsofacuteexacerbationbetweensmokingassociatedcopdandtuberculosisassociatedcopd ‡A Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD ‡9 1 | ||
| 919 | ‡a effectsoftransglutaminase2inhibitiononventilatorinducedlunginjury ‡A Effects of transglutaminase 2 inhibition on ventilator-induced lung injury. ‡9 1 | ||
| 919 | ‡a increasedurinary50histidineinpatientswithasthmacopdoverlapapilotstudy ‡A Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study. ‡9 1 | ||
| 919 | ‡a infectionincreasesthereadmissionrateofcopdpatients ‡A infection increases the readmission rate of COPD patients ‡9 1 | ||
| 919 | ‡a invasiveendobronchialmycobacteriumkansasiiinfection ‡A Invasive Endobronchial Mycobacterium kansasii Infection ‡9 1 | ||
| 919 | ‡a phase2openlabelmulticenterstudytoassesstheantitumoractivityofafatinibinlungcancerpatientswithactivatingepidermalgrowthfactorreceptormutationfromcirculatingtumordnaliquidlunga ‡A Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A ‡9 1 | ||
| 919 | ‡a presenceoflungcancerandhighgenderageandphysiologyscoreaspredictorsofacuteexacerbationincombinedpulmonaryfibrosisandemphysemaaretrospectivestudy ‡A Presence of lung cancer and high gender, age, and physiology score as predictors of acute exacerbation in combined pulmonary fibrosis and emphysema: A retrospective study ‡9 1 | ||
| 919 | ‡a prognosticfactorsandskeletalrelatedeventsinpatientswithsmallcelllungcancerwithbonemetastasesatthetimeofdiagnosis ‡A Prognostic Factors and Skeletal-Related Events in Patients with Small Cell Lung Cancer with Bone Metastases at the Time of Diagnosis. ‡9 1 | ||
| 919 | ‡a realworlduseofosimertinibinnonsmallcelllungcancerastrisstudykoreansubgroupanalysis ‡A Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis ‡9 1 | ||
| 919 | ‡a respiratorybronchiolitisassociatedinterstitiallungdiseaseinanonsmokerradiologicandpathologicfindings ‡A Respiratory bronchiolitis-associated interstitial lung disease in a nonsmoker: radiologic and pathologic findings ‡9 1 | ||
| 919 | ‡a associationbetweenbloodeosinophilpercentandbacterialinfectioninacuteexacerbationofchronicobstructivepulmonarydisease ‡A The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease. ‡9 1 | ||
| 919 | ‡a clinicalefficacyandsafetyof4weeklydocetaxelas1linetherapyinelderlylungcancerpatientswithsquamouscellcarcinoma ‡A The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma ‡9 1 | ||
| 919 | ‡a clinicalsignificanceofraspik3caandptenmutationsinnonsmallcelllungcancerusingcellfreedna ‡A The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA ‡9 1 | ||
| 919 | ‡a effectofaniκbkinaseβ ‡A The effect of an IκB-kinase-β ‡9 1 | ||
| 919 | ‡a effectofaniκbkinaseβikkβinhibitorontobaccosmokeinducedpulmonaryinflammation ‡A The effect of an IκB-kinase-β(IKKβ) inhibitor on tobacco smoke-induced pulmonary inflammation ‡9 1 | ||
| 919 | ‡a comparisonoftheefficacybetweenpemetrexedplusplatinumandnonpemetrexedplusplatinumas1linetreatmentinpatientswithwildtypeepidermalgrowthfactorreceptornonsquamousnonsmallcelllungcanceraretrospectiveanalysis ‡A Comparison of the Efficacy between Pemetrexed plus Platinum and Non-Pemetrexed plus Platinum as First-Line Treatment in Patients with Wild-Type Epidermal Growth Factor Receptor Nonsquamous Non-Small Cell Lung Cancer: A Retrospective Analysis ‡9 1 | ||
| 919 | ‡a clinicaleffectivenessofhighflownasalcannulainhypoxaemicpatientsduringbronchoscopicprocedures ‡A Clinical Effectiveness of High-Flow Nasal Cannula in Hypoxaemic Patients during Bronchoscopic Procedures. ‡9 1 | ||
| 919 | ‡a decreasedserumclubcellsecretoryproteininasthmaandchronicobstructivepulmonarydiseaseoverlapapilotstudy ‡A Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study ‡9 1 | ||
| 919 | ‡a clinicalcharacteristicsandtreatmentofimmunerelatedadverseeventsofimmunecheckpointinhibitors ‡A Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors ‡9 1 | ||
| 919 | ‡a chemotherapyactsasanadjuvanttoconvertthetumormicroenvironmentintoahighlypermissivestateforvaccinationinducedantitumorimmunity ‡A Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity ‡9 1 | ||
| 919 | ‡a bacterialandviralidentificationrateinacuteexacerbationofchronicobstructivepulmonarydiseaseinkorea ‡A Bacterial and Viral Identification Rate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea ‡9 1 | ||
| 919 | ‡a asthmalikesymptomsareincreasedinthemetabolicsyndrome ‡A Asthma-like symptoms are increased in the metabolic syndrome ‡9 1 | ||
| 996 | ‡2 ISNI|0000000473498209 | ||
| 996 | ‡2 ISNI|000000002340202X | ||
| 996 | ‡2 ISNI|0000000492402890 | ||
| 996 | ‡2 ISNI|0000000513331762 | ||
| 996 | ‡2 ISNI|0000000468261311 | ||
| 996 | ‡2 ISNI|0000000473725360 | ||
| 996 | ‡2 DNB|129908398 | ||
| 996 | ‡2 LC|no2004057666 | ||
| 996 | ‡2 ISNI|0000000080031763 | ||
| 996 | ‡2 ISNI|0000000473908992 | ||
| 996 | ‡2 ISNI|0000000480116408 | ||
| 996 | ‡2 ISNI|0000000042616971 | ||
| 996 | ‡2 PLWABN|9810555593705606 | ||
| 996 | ‡2 ISNI|0000000477265998 | ||
| 996 | ‡2 ISNI|0000000464769310 | ||
| 996 | ‡2 ISNI|0000000464408451 | ||
| 996 | ‡2 ISNI|0000000479029796 | ||
| 996 | ‡2 NUKAT|n 2017156768 | ||
| 996 | ‡2 ISNI|000000012649406X | ||
| 996 | ‡2 BIBSYS|99051271 | ||
| 996 | ‡2 ISNI|0000000461118467 | ||
| 996 | ‡2 LC|n 79135959 | ||
| 996 | ‡2 DNB|110841719 | ||
| 996 | ‡2 ISNI|0000000493204431 | ||
| 996 | ‡2 ISNI|0000000478840878 | ||
| 996 | ‡2 SUDOC|030773342 | ||
| 996 | ‡2 ISNI|0000000465012758 | ||
| 996 | ‡2 ISNI|0000000516823359 | ||
| 996 | ‡2 LC|no2010166224 | ||
| 996 | ‡2 ISNI|0000000475247227 | ||
| 996 | ‡2 ISNI|0000000505250962 | ||
| 996 | ‡2 ISNI|0000000511053471 | ||
| 996 | ‡2 ISNI|0000000509798503 | ||
| 996 | ‡2 J9U|987009165448505171 | ||
| 996 | ‡2 ISNI|0000000493937758 | ||
| 996 | ‡2 LC|n 83145047 | ||
| 996 | ‡2 DNB|119198061 | ||
| 996 | ‡2 ISNI|0000000477370026 | ||
| 996 | ‡2 DNB|128777419 | ||
| 996 | ‡2 ISNI|0000000459436706 | ||
| 996 | ‡2 ISNI|0000000467775302 | ||
| 996 | ‡2 DNB|131446614 | ||
| 996 | ‡2 DNB|1166989518 | ||
| 996 | ‡2 ISNI|0000000468603502 | ||
| 996 | ‡2 ISNI|0000000475184561 | ||
| 996 | ‡2 ISNI|0000000491604079 | ||
| 996 | ‡2 ISNI|0000000502792125 | ||
| 996 | ‡2 ISNI|0000000480258625 | ||
| 996 | ‡2 DNB|122010426 | ||
| 996 | ‡2 LC|n 89668581 | ||
| 996 | ‡2 ISNI|0000000505937078 | ||
| 996 | ‡2 BIBSYS|90519814 | ||
| 996 | ‡2 BNF|15598725 | ||
| 996 | ‡2 ISNI|0000000493354704 | ||
| 996 | ‡2 LC|n 2016010879 | ||
| 996 | ‡2 ISNI|0000000464851007 | ||
| 996 | ‡2 ISNI|0000000081246715 | ||
| 996 | ‡2 LC|nb2014000455 | ||
| 996 | ‡2 ISNI|0000000465014630 | ||
| 996 | ‡2 ISNI|0000000475375472 | ||
| 996 | ‡2 ISNI|0000000494128872 | ||
| 996 | ‡2 PLWABN|9810816657305606 | ||
| 996 | ‡2 ISNI|0000000505817842 | ||
| 996 | ‡2 ISNI|0000000360261766 | ||
| 996 | ‡2 NSK|000346984 | ||
| 996 | ‡2 CAOONL|ncf11204999 | ||
| 996 | ‡2 BNF|12305277 | ||
| 996 | ‡2 BIBSYS|13048634 | ||
| 996 | ‡2 ISNI|0000000505486190 | ||
| 996 | ‡2 ISNI|000000047370077X | ||
| 996 | ‡2 ISNI|0000000493973521 | ||
| 996 | ‡2 ISNI|0000000465047125 | ||
| 996 | ‡2 ISNI|0000000474232007 | ||
| 996 | ‡2 ISNI|0000000063984810 | ||
| 996 | ‡2 ISNI|0000000505487054 | ||
| 996 | ‡2 ISNI|0000000467959048 | ||
| 996 | ‡2 ISNI|0000000491817023 | ||
| 996 | ‡2 ISNI|0000000460884645 | ||
| 996 | ‡2 LC|no2010086487 | ||
| 996 | ‡2 ISNI|0000000468042514 | ||
| 996 | ‡2 SUDOC|252624459 | ||
| 996 | ‡2 LC|no2018034966 | ||
| 996 | ‡2 DNB|129560286 | ||
| 996 | ‡2 ISNI|0000000473771009 | ||
| 996 | ‡2 ISNI|0000000463239676 | ||
| 996 | ‡2 ISNI|0000000503707922 | ||
| 996 | ‡2 ISNI|0000000492332458 | ||
| 996 | ‡2 ISNI|0000000505487839 | ||
| 996 | ‡2 ISNI|0000000071306956 | ||
| 996 | ‡2 ISNI|0000000505099940 | ||
| 996 | ‡2 ISNI|0000000063979608 | ||
| 996 | ‡2 DNB|1159909687 | ||
| 996 | ‡2 ISNI|0000000513375001 | ||
| 996 | ‡2 ISNI|0000000465049710 | ||
| 996 | ‡2 ISNI|0000000464774654 | ||
| 996 | ‡2 J9U|987007369501905171 | ||
| 996 | ‡2 ISNI|0000000493142453 | ||
| 996 | ‡2 ISNI|0000000473929611 | ||
| 996 | ‡2 LNB|LNC10-000036813 | ||
| 996 | ‡2 DNB|13534445X | ||
| 996 | ‡2 ISNI|000000046798100X | ||
| 996 | ‡2 LC|n 2020031524 | ||
| 996 | ‡2 ISNI|000000047357083X | ||
| 996 | ‡2 ISNI|0000000505489674 | ||
| 996 | ‡2 ISNI|0000000467987778 | ||
| 996 | ‡2 ISNI|0000000382886484 | ||
| 996 | ‡2 ISNI|0000000505742326 | ||
| 996 | ‡2 NTA|110256859 | ||
| 996 | ‡2 ISNI|0000000483893763 | ||
| 996 | ‡2 LC|no2022119496 | ||
| 996 | ‡2 ISNI|000000051368375X | ||
| 996 | ‡2 SZ|123919496X | ||
| 996 | ‡2 ISNI|0000000472476892 | ||
| 996 | ‡2 ISNI|000000051346993X | ||
| 996 | ‡2 ISNI|0000000464457122 | ||
| 996 | ‡2 DNB|1089665733 | ||
| 996 | ‡2 LC|n 88291728 | ||
| 996 | ‡2 ISNI|0000000483599409 | ||
| 996 | ‡2 ISNI|0000000468289672 | ||
| 996 | ‡2 LC|n 2021050405 | ||
| 996 | ‡2 ISNI|0000000473702804 | ||
| 996 | ‡2 ISNI|0000000477294051 | ||
| 996 | ‡2 ISNI|0000000465073630 | ||
| 996 | ‡2 ISNI|0000000464872190 | ||
| 996 | ‡2 NKC|ntk2013743123 | ||
| 996 | ‡2 ISNI|0000000480086050 | ||
| 996 | ‡2 ISNI|0000000509015302 | ||
| 996 | ‡2 ISNI|0000000436939554 | ||
| 996 | ‡2 ISNI|0000000491824346 | ||
| 996 | ‡2 ISNI|000000046795989X | ||
| 996 | ‡2 ISNI|0000000485126613 | ||
| 996 | ‡2 ISNI|0000000513519028 | ||
| 996 | ‡2 NSK|000465796 | ||
| 996 | ‡2 ISNI|0000000465170780 | ||
| 996 | ‡2 ISNI|0000000464592236 | ||
| 996 | ‡2 ISNI|0000000468342007 | ||
| 996 | ‡2 ISNI|0000000479568941 | ||
| 996 | ‡2 CAOONL|ncf11067434 | ||
| 996 | ‡2 NTA|242263844 | ||
| 996 | ‡2 ISNI|0000000492264758 | ||
| 996 | ‡2 ISNI|0000000483439368 | ||
| 996 | ‡2 NII|DA12031089 | ||
| 996 | ‡2 ISNI|0000000464300504 | ||
| 996 | ‡2 ISNI|0000000464630394 | ||
| 996 | ‡2 LC|no2021105274 | ||
| 996 | ‡2 ISNI|0000000493984773 | ||
| 996 | ‡2 NUKAT|n 2011170660 | ||
| 996 | ‡2 ISNI|0000000492999703 | ||
| 996 | ‡2 ISNI|000000051143571X | ||
| 996 | ‡2 LC|n 85008738 | ||
| 996 | ‡2 ISNI|0000000509055726 | ||
| 996 | ‡2 ISNI|0000000492276134 | ||
| 996 | ‡2 ISNI|0000000461009607 | ||
| 996 | ‡2 ISNI|0000000467777308 | ||
| 996 | ‡2 ISNI|0000000474042457 | ||
| 996 | ‡2 ISNI|0000000505096870 | ||
| 996 | ‡2 ISNI|0000000505480522 | ||
| 996 | ‡2 ISNI|0000000064329332 | ||
| 996 | ‡2 LC|no2004062674 | ||
| 996 | ‡2 ISNI|0000000464696828 | ||
| 996 | ‡2 ISNI|0000000505489324 | ||
| 996 | ‡2 BNF|15039814 | ||
| 996 | ‡2 ISNI|0000000467960743 | ||
| 996 | ‡2 ISNI|0000000479363719 | ||
| 996 | ‡2 ISNI|0000000513541647 | ||
| 996 | ‡2 DNB|1159321310 | ||
| 996 | ‡2 ISNI|0000000505485884 | ||
| 996 | ‡2 ISNI|0000000467958184 | ||
| 996 | ‡2 BNE|XX1684609 | ||
| 996 | ‡2 ISNI|0000000467964402 | ||
| 996 | ‡2 LC|no2009188635 | ||
| 996 | ‡2 ISNI|0000000467672119 | ||
| 996 | ‡2 DNB|1063987601 | ||
| 996 | ‡2 DNB|1074212983 | ||
| 996 | ‡2 ISNI|0000000461101761 | ||
| 996 | ‡2 DNB|173201717 | ||
| 996 | ‡2 ISNI|0000000477163094 | ||
| 996 | ‡2 ISNI|0000000505368880 | ||
| 996 | ‡2 ISNI|000000050549342X | ||
| 996 | ‡2 NTA|357494997 | ||
| 996 | ‡2 ISNI|0000000474006536 | ||
| 996 | ‡2 NUKAT|n 2012073711 | ||
| 996 | ‡2 LC|n 87106638 | ||
| 996 | ‡2 ISNI|0000000509112700 | ||
| 996 | ‡2 ISNI|0000000467665779 | ||
| 996 | ‡2 ISNI|0000000467679281 | ||
| 996 | ‡2 ISNI|0000000463654730 | ||
| 996 | ‡2 ISNI|0000000426092468 | ||
| 996 | ‡2 DNB|1074172736 | ||
| 996 | ‡2 LC|no 89000936 | ||
| 996 | ‡2 LIH|LNB:CC51;=_h_9 | ||
| 996 | ‡2 ISNI|0000000473973292 | ||
| 996 | ‡2 LC|n 00120846 | ||
| 996 | ‡2 ISNI|0000000067740346 | ||
| 996 | ‡2 ISNI|0000000460267794 | ||
| 996 | ‡2 ISNI|0000000493966962 | ||
| 996 | ‡2 ISNI|000000050525113X | ||
| 996 | ‡2 ISNI|0000000479174854 | ||
| 996 | ‡2 ISNI|0000000465575198 | ||
| 996 | ‡2 ISNI|0000000492080975 | ||
| 996 | ‡2 NLA|000035416424 | ||
| 996 | ‡2 ISNI|0000000467826683 | ||
| 996 | ‡2 ISNI|0000000513306428 | ||
| 996 | ‡2 ISNI|000000049172146X | ||
| 996 | ‡2 ISNI|0000000504414910 | ||
| 996 | ‡2 ISNI|0000000479264104 | ||
| 996 | ‡2 ISNI|0000000480257817 | ||
| 996 | ‡2 ISNI|0000000479294549 | ||
| 996 | ‡2 ISNI|0000000467677008 | ||
| 996 | ‡2 ISNI|0000000511740247 | ||
| 996 | ‡2 ISNI|0000000465773987 | ||
| 996 | ‡2 ISNI|0000000502743155 | ||
| 996 | ‡2 ISNI|0000000072655592 | ||
| 996 | ‡2 ISNI|0000000464784705 | ||
| 996 | ‡2 ISNI|0000000505487986 | ||
| 996 | ‡2 BNCHL|10000000000000000132854 | ||
| 996 | ‡2 NII|DA02538696 | ||
| 996 | ‡2 ISNI|0000000514734627 | ||
| 996 | ‡2 ISNI|0000000473863210 | ||
| 996 | ‡2 ISNI|000000047395426X | ||
| 996 | ‡2 ISNI|0000000477849547 | ||
| 996 | ‡2 ISNI|0000000464188989 | ||
| 996 | ‡2 DNB|1278910565 | ||
| 996 | ‡2 LC|n 87840682 | ||
| 996 | ‡2 ISNI|0000000476729033 | ||
| 996 | ‡2 ISNI|0000000024173708 | ||
| 996 | ‡2 ISNI|0000000460317405 | ||
| 996 | ‡2 ISNI|0000000479181210 | ||
| 996 | ‡2 LC|n 2009065556 | ||
| 996 | ‡2 JPG|500284459 | ||
| 996 | ‡2 ISNI|0000000492885917 | ||
| 996 | ‡2 BIBSYS|90152113 | ||
| 996 | ‡2 DNB|123919496X | ||
| 996 | ‡2 ISNI|0000000503372560 | ||
| 996 | ‡2 ISNI|000000049308314X | ||
| 996 | ‡2 ISNI|0000000509416552 | ||
| 996 | ‡2 ISNI|0000000493030515 | ||
| 996 | ‡2 NSK|000734848 | ||
| 996 | ‡2 ISNI|0000000473514213 | ||
| 996 | ‡2 SZ|132384833 | ||
| 996 | ‡2 J9U|987007406997105171 | ||
| 996 | ‡2 DNB|1075604192 | ||
| 996 | ‡2 LC|no2011184098 | ||
| 996 | ‡2 ISNI|0000000467775767 | ||
| 996 | ‡2 ISNI|0000000493963112 | ||
| 996 | ‡2 ISNI|0000000478583189 | ||
| 996 | ‡2 ISNI|0000000480202402 | ||
| 996 | ‡2 ISNI|0000000464723072 | ||
| 996 | ‡2 ISNI|0000000467852080 | ||
| 996 | ‡2 ISNI|0000000491934289 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
